Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF JULY 27, 2017 FBO #5725
SOLICITATION NOTICE

R -- ARV and Generic Pharmaceutical Data - Request for Proposal (RFP)

Notice Date
7/25/2017
 
Notice Type
Combined Synopsis/Solicitation
 
NAICS
541990 — All Other Professional, Scientific, and Technical Services
 
Contracting Office
Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
 
ZIP Code
30341-4146
 
Solicitation Number
2017-N-66822
 
Archive Date
8/23/2017
 
Point of Contact
Lee Catherine Kennedy, Phone: 770-488-2673
 
E-Mail Address
vhg0@cdc.gov
(vhg0@cdc.gov)
 
Small Business Set-Aside
N/A
 
Description
This is a MS Word-version of Section B (Continuation of SF1449). This is the Appendix, with supplemental tables as referenced in the RFP. This document contains technical evaluation factors. This is the full Request for Proposal (RFP) document. The purpose of this contract is to provide the Government with nationwide ARV drug use data that includes demographic data and linked medical claims data, so that these data can be stratified by national, state, and MSA level for the years 2013-2016. If the Government elects to exercise option years, subsequent years of data will be acquired each year, for example in Option Period 1, data from 2017 will be purchased, in Option Period 2, data from 2018, etc. The analyses to be conducted using these data will assess the uptake of PrEP and PEP and produce national estimates; duration of and adherence to HIV treatment; quality of PrEP and HIV care; costs of care; co-morbidities among patients included in the database. The analyses will use combinations of diagnosis codes (ICD-9/ ICD-10), procedure codes (CPT), and drug codes (NDC) to identify diagnoses, procedures such as lab testing, and prescribed medications. Additionally, analyses will also be done to assess differences in HIV prevention and treatment by demographic characteristics (e.g., age, sex, race/ethnicity) and geographic factors (e.g., region, state, urban/rural, county, MSA) to identify disparities in utilization.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/2017-N-66822/listing.html)
 
Place of Performance
Address: All performance associated with this requirement will be performed at the Contractor's facility., United States
 
Record
SN04596984-W 20170727/170726043008-951095a9eb909e3476280bffdd45a2c2 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.